Related Experiment Video

Updated: Jun 23, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Stent thrombosis after percutaneous coronary intervention for bifurcation lesions

Huay-Cheem Tan1

  • 1National University Heart Centre, Singapore, National University Health System, Singapore. cheem001@pacific.net.sg

Journal of Interventional Cardiology
|April 22, 2009
PubMed

Insights

Percutaneous coronary intervention (PCI) for bifurcation lesions has a low risk of stent thrombosis (ST) with drug-eluting stents. Careful technique and dual antiplatelet therapy are key for preventing ST in these complex cases.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Percutaneous coronary intervention (PCI) in bifurcation lesions carries a higher complication risk than non-bifurcation lesions.
  • Stent thrombosis (ST) is a serious concern in the drug-eluting stent (DES) era, particularly for complex PCI procedures.
  • Understanding ST risk in bifurcation PCI is crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the risk of stent thrombosis (ST) in percutaneous coronary intervention (PCI) of bifurcation lesions.
  • To compare ST risk between different stenting strategies (two-stent vs. provisional) in bifurcation PCI.
  • To assess the impact of drug-eluting stents (DES) versus bare metal stents (BMS) on ST risk in bifurcation PCI.

Main Methods:

  • Review of clinical data and outcomes for patients undergoing PCI of bifurcation lesions.
  • Comparative analysis of stent thrombosis rates based on stenting strategy and stent type.
  • Analysis of factors contributing to stent thrombosis in bifurcation interventions.

Main Results:

  • The risk of stent thrombosis (ST) in PCI of bifurcation lesions remains low, even with two-stent strategies compared to provisional side branch stenting.
  • Drug-eluting stents (DES) do not confer a higher risk of ST compared to bare metal stents (BMS) in bifurcation PCI.
  • Meticulous procedural technique and appropriate antiplatelet therapy are critical for preventing ST.

Conclusions:

  • PCI of bifurcation lesions can be performed with a low risk of ST, particularly with modern DES.
  • Optimal prevention of ST involves appropriate duration of dual antiplatelet therapy, precise stent deployment, and consideration of intravascular ultrasound guidance.
  • Adherence to best practices minimizes the catastrophic late occurrence of ST in bifurcation interventions.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...